热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　三生制药（01530）发布公告，认购事项的所有先决条件已达成，并于2025年8月1日完成。合共3114.25万股认购股份已按认购价每股认购股份25.2055港元成功发行予辉瑞。认购股份占紧接认购完成前公司现有已发行股本的约1.30%；及通过发行及配发认购股份扩大股本规模后的公司已发行股本的约1.28%。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.